2566 — Hangzhou Jiuyuan Genetic Biopharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- HK$1.45bn
- HK$1.00bn
- CNY1.37bn
- 73
- 68
- 36
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.92 | ||
| Price to Tang. Book | 1.03 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.02 | ||
| EV to EBITDA | 4.61 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.12% | ||
| Return on Equity | 11.47% | ||
| Operating Margin | 12.84% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | 1,307.25 | 1,125.4 | 1,287.41 | 1,369.18 | n/a | n/a | 1.55% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -49.69 | +116.03 | +26.05 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd, formerly Hangzhou Jiuyuan Gene Engineering Co Ltd, is a China-based company principally engaged in the research, development, manufacturing and commercialization of biopharmaceutical products and medical devices. The Company focuses on orthopedics, metabolic diseases, oncology and blood treatment. The Company's orthopedic products include Guyoudao bone repair materials. The Company's oncology products include Jilifen, Jijufen, Jiouting, Jifuwei, and Jitansu. The Company's blood products include Jipailin and Yinuojia. The Company's products are mainly used to treat diseases such as diabetes, multiple myeloma, thrombocytopenia, and neutropenia. The Company mainly operates its businesses in the domestic and overseas markets.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 31st, 1993
- Public Since
- November 28th, 2024
- No. of Employees
- 1,541
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 245,398,800
- Address
- No. 23, No. 8 Avenue,, HANGZHOU
- Web
- https://www.china-gene.com/
- Phone
- +86 57186910099
- Auditors
- Ernst & Young
Upcoming Events for 2566
Similar to 2566
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Hangzhou Jiuyuan Genetic Biopharmaceutical Co share price?
As of Today at 21:28 UTC, shares in Hangzhou Jiuyuan Genetic Biopharmaceutical Co are trading at HK$6.06. This share price information is delayed by 15 minutes.
How has the Hangzhou Jiuyuan Genetic Biopharmaceutical Co share price performed this year?
Shares in Hangzhou Jiuyuan Genetic Biopharmaceutical Co last closed at HK$6.06 and the price had moved by over the past 365 days. In terms of relative price strength the Hangzhou Jiuyuan Genetic Biopharmaceutical Co share price has matched the FTSE Developed Asia Pacific Index by over the past year.
What are the analyst and broker recommendations for Hangzhou Jiuyuan Genetic Biopharmaceutical Co?
There is no consensus recommendation for this security.
Find out moreWhat is the Hangzhou Jiuyuan Genetic Biopharmaceutical Co dividend yield?
The Hangzhou Jiuyuan Genetic Biopharmaceutical Co dividend yield is 0.98% based on the trailing twelve month period.
Does Hangzhou Jiuyuan Genetic Biopharmaceutical Co pay a dividend?
Last year, Hangzhou Jiuyuan Genetic Biopharmaceutical Co paid a total dividend of CNY0.06, and it currently has a trailing dividend yield of 0.98%.Looking ahead, shares in Hangzhou Jiuyuan Genetic Biopharmaceutical Co are due to go ex-dividend on 2025-06-13 and the next dividend pay date is 2025-07-30.
When does Hangzhou Jiuyuan Genetic Biopharmaceutical Co next pay dividends?
Hangzhou Jiuyuan Genetic Biopharmaceutical Co are due to go ex-dividend on 2025-06-13 and the next dividend pay date is 2025-07-30. The historic dividend yield on Hangzhou Jiuyuan Genetic Biopharmaceutical Co shares is currently 0.98%.
How do I buy Hangzhou Jiuyuan Genetic Biopharmaceutical Co shares?
To buy shares in Hangzhou Jiuyuan Genetic Biopharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hangzhou Jiuyuan Genetic Biopharmaceutical Co?
As of the previous close price of HK$6.06, shares in Hangzhou Jiuyuan Genetic Biopharmaceutical Co had a market capitalisation of HK$1.45bn.
Where are Hangzhou Jiuyuan Genetic Biopharmaceutical Co shares listed?
Here are the trading details for Hangzhou Jiuyuan Genetic Biopharmaceutical Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2566
What kind of share is Hangzhou Jiuyuan Genetic Biopharmaceutical Co?
Based on an overall assessment of its quality, value and momentum Hangzhou Jiuyuan Genetic Biopharmaceutical Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hangzhou Jiuyuan Genetic Biopharmaceutical Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Hangzhou Jiuyuan Genetic Biopharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hangzhou Jiuyuan Genetic Biopharmaceutical Co. Over the past six months, its share price has matched the FTSE Developed Asia Pacific Index by .
As of the last closing price of HK$6.06, shares in Hangzhou Jiuyuan Genetic Biopharmaceutical Co were trading -7.36% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hangzhou Jiuyuan Genetic Biopharmaceutical Co PE Ratio?
The Hangzhou Jiuyuan Genetic Biopharmaceutical Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$6.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hangzhou Jiuyuan Genetic Biopharmaceutical Co?
We do not have data on Hangzhou Jiuyuan Genetic Biopharmaceutical Co's directors